Status:
RECRUITING
Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions
Lead Sponsor:
Norwegian Institute of Public Health
Conditions:
Breast Cancer Patients
Health, Subjective
Eligibility:
FEMALE
20-69 years
Phase:
NA
Brief Summary
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with ...
Detailed Description
After completing the baseline HRQoL assessment, eligible breast cancer patients will be invited to participate in a randomized clinical trial. Those who are willing will be randomly allocated to one ...
Eligibility Criteria
Inclusion
- first occurrence breast cancer diagnosed from Jan 1, 2020
- non-metastatic cancer stage 0-III
- Invasive tumors must be:
- HER2 positive (regardless of ER, PR) or
- ER negative
- (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)
Exclusion
- None
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT04480203
Start Date
January 15 2021
End Date
December 31 2035
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Registry of Norway
Oslo, Norway, 0379